tibolone has been researched along with Osteoporotic Fractures in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elgebaly, Z; Elliott, J; Naik-Panvelkar, P; Norman, S; Pollack, A; Seibel, MJ; Thistlethwaite, J; Weston, C | 1 |
| Black, DM; Cheung, AM; Eastell, R; Murad, MH; Rosen, CJ; Shoback, D | 1 |
| Al Nofal, A; Alahdab, F; Almasri, J; Asi, N; Barrionuevo, P; Benkhadra, K; Farah, W; Haydour, Q; Kapoor, E; Mohammed, K; Murad, MH; Muthusamy, K; Sarigianni, M; Wang, Z | 1 |
| de Melo, NR; Pompei, LM | 1 |
1 review(s) available for tibolone and Osteoporotic Fractures
| Article | Year |
|---|---|
Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hip Fractures; Humans; Network Meta-Analysis; Norpregnenes; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause; Selective Estrogen Receptor Modulators; Spinal Fractures; Vitamin D | 2019 |
3 other study(ies) available for tibolone and Osteoporotic Fractures
| Article | Year |
|---|---|
Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.
Topics: Aged; Aged, 80 and over; Attitude of Health Personnel; Australia; Bone Density Conservation Agents; Denosumab; Deprescriptions; Diphosphonates; Drug Substitution; Female; General Practice; General Practitioners; Humans; Longitudinal Studies; Male; Middle Aged; Norpregnenes; Osteoporosis; Osteoporotic Fractures; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Retrospective Studies; Teriparatide; Thiophenes | 2020 |
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.
Topics: Absorptiometry, Photon; Accidental Falls; Bone Density Conservation Agents; Calcitonin; Calcium; Clinical Decision-Making; Denosumab; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Parathyroid Hormone-Related Protein; Patient Preference; Raloxifene Hydrochloride; Risk Assessment; Risk Reduction Behavior; Selective Estrogen Receptor Modulators; Teriparatide; Vitamin D | 2019 |
Tibolone reduces osteoporotic fracture risk and breast cancer risk, but increases the risk of stroke.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Norpregnenes; Osteoporotic Fractures; Stroke | 2010 |